Raymond James & Associates »

Intellia Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.3M 155k 27.51
2023-12-31 $4.1M 134k 30.49
2023-09-30 $3.3M 104k 31.62
2023-06-30 $2.9M 70k 40.78
2023-03-31 $2.0M 53k 37.27
2022-12-31 $736k 21k 34.89
2022-09-30 $1.0M 18k 55.97
2022-06-30 $705k 14k 51.78
2022-03-31 $1.0M 14k 72.70
2021-12-31 $2.0M 17k 118.25
2021-09-30 $3.8M 28k 134.14
2021-06-30 $4.0M 25k 161.91
2021-03-31 $2.1M 26k 80.26
2020-12-31 $998k 18k 54.40
2020-09-30 $261k 13k 19.88
2020-06-30 $368k 18k 21.05
2020-03-31 $228k 19k 12.25
2019-12-31 $268k 18k 14.67
2018-06-30 $238k 8.7k 27.39
2018-03-31 $264k 13k 21.07